Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amarendra Pegu

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Biorxiv : the Preprint Server for Biology|May 25, 2021
Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah O'Connell, Stephen D Schmidt, et al.
Nature Communications|June 22, 2023
Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infectionsWanwisa Promsote, Ling Xu, Jason Hataye, et al.
Cell Reports|February 15, 2018
Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing AntibodyYoung D Kwon, Gwo-Yu Chuang, Baoshan Zhang, et al.
Science Translational Medicine|January 20, 2017
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodiesConstantinos Petrovas, Sara Ferrando-Martinez, Michael Y Gerner, et al.
The Journal of Clinical Investigation|March 18, 2020
Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral reboundEvan M Cale, Hongjun Bai, Meera Bose, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 5, 2024
Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1Jianliang Xu, Tongqing Zhou, Krisha McKee, et al.
Nature Communications|August 28, 2024
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIV<sub>AD8-EO</sub> infectionJoana Dias, Giulia Fabozzi, Slim Fourati, et al.
Journal of Virology|October 16, 2015
New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional PotencyNicole A Doria-Rose, Jinal N Bhiman, Ryan S Roark, et al.
Journal of Virology|April 8, 2016
Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based DesignYoung D Kwon, Ivelin S Georgiev, Gilad Ofek, et al.
Science (New York, N.Y.)|September 22, 2017
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaquesLing Xu, Amarendra Pegu, Ercole Rao, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|May 25, 2021
Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah O'Connell, Stephen D Schmidt, et al.
Nature Communications|June 22, 2023
Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infectionsWanwisa Promsote, Ling Xu, Jason Hataye, et al.
Cell Reports|February 15, 2018
Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing AntibodyYoung D Kwon, Gwo-Yu Chuang, Baoshan Zhang, et al.
Science Translational Medicine|January 20, 2017
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodiesConstantinos Petrovas, Sara Ferrando-Martinez, Michael Y Gerner, et al.
The Journal of Clinical Investigation|March 18, 2020
Neutralizing antibody VRC01 failed to select for HIV-1 mutations upon viral reboundEvan M Cale, Hongjun Bai, Meera Bose, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 5, 2024
Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1Jianliang Xu, Tongqing Zhou, Krisha McKee, et al.
Nature Communications|August 28, 2024
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIV<sub>AD8-EO</sub> infectionJoana Dias, Giulia Fabozzi, Slim Fourati, et al.
Journal of Virology|October 16, 2015
New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional PotencyNicole A Doria-Rose, Jinal N Bhiman, Ryan S Roark, et al.
Journal of Virology|April 8, 2016
Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based DesignYoung D Kwon, Ivelin S Georgiev, Gilad Ofek, et al.
Science (New York, N.Y.)|September 22, 2017
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaquesLing Xu, Amarendra Pegu, Ercole Rao, et al.
Pageof 9